Skip to main content
Erschienen in: International Urology and Nephrology 1/2010

01.03.2010 | Nephrology - Review

Hematologic abnormalities following renal transplantation

verfasst von: Mark A. Marinella

Erschienen in: International Urology and Nephrology | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Recipients of renal allografts are surviving longer and, consequently, may experience a variety of complications related not only to the transplanted kidney, but also to the hematopoietic system. Common hematologic complications in the renal transplant patient include abnormalities of one cell line, such as post-transplantation erythrocytosis or anemia, that are often treatable with simple measures. Conversely, pathologies involving the leukocyte and platelet population often exist in the context of pancytopenia, which may be a manifestation of systemic infection (e.g., cytomegalovirus, human herpesvirus 8) or malignancy (post-transplantation lymphoproliferative disorders). Uncommon, but life-threatening, processes complicating renal transplantation include hepatosplenic γδ T-cell lymphoma and viral-induced hemophagocytic syndrome, both of which are associated with severe pancytopenia and, often, death. Since this patient population is often managed in a multidisciplinary fashion by nephrologists, infection specialists, transplant surgeons, hematologists, and internal medicine physicians, a succinct review of this topic is warranted.
Literatur
1.
Zurück zum Zitat Karakus S, Kanbay M, Koseoglu HK, Colak T, Haberal M (2004) Causes of anemia in renal transplant recipients. Transplant Proc 36:164–165PubMedCrossRef Karakus S, Kanbay M, Koseoglu HK, Colak T, Haberal M (2004) Causes of anemia in renal transplant recipients. Transplant Proc 36:164–165PubMedCrossRef
4.
5.
Zurück zum Zitat Sauron P, Berthoux P, Berthoux F (1993) New insights and treatment in post-transplant polycythemia (erythrocytosis) of renal recipients. Transplant Proc 25:1032–1033PubMed Sauron P, Berthoux P, Berthoux F (1993) New insights and treatment in post-transplant polycythemia (erythrocytosis) of renal recipients. Transplant Proc 25:1032–1033PubMed
6.
Zurück zum Zitat Hirakata H, Onoyama K, Iseki K, Kumagai H, Fujimi S, Omae T (1984) Worsening of anemia induced by long-term use of captopril in hemodialysis patients. Am J Nephrol 4:355–360. doi:10.1159/000166851 PubMedCrossRef Hirakata H, Onoyama K, Iseki K, Kumagai H, Fujimi S, Omae T (1984) Worsening of anemia induced by long-term use of captopril in hemodialysis patients. Am J Nephrol 4:355–360. doi:10.​1159/​000166851 PubMedCrossRef
7.
Zurück zum Zitat Wang AY, Yu AW, Lam CW et al (2002) Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis. Am J Kidney Dis 39:600–608. doi:10.1053/ajkd.2002.31404 PubMedCrossRef Wang AY, Yu AW, Lam CW et al (2002) Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis. Am J Kidney Dis 39:600–608. doi:10.​1053/​ajkd.​2002.​31404 PubMedCrossRef
9.
Zurück zum Zitat Glicklich D, Burris L, Urban A et al (2001) Angiotensin-converting enzyme inhibition induces apoptosis in erythroid precursors and affects insulin-like growth factor-1 in posttransplantation erythrocytosis. J Am Soc Nephrol 12:1958–1964PubMed Glicklich D, Burris L, Urban A et al (2001) Angiotensin-converting enzyme inhibition induces apoptosis in erythroid precursors and affects insulin-like growth factor-1 in posttransplantation erythrocytosis. J Am Soc Nephrol 12:1958–1964PubMed
10.
Zurück zum Zitat Wickre CG, Normal DJ, Bennison A et al (1983) Postrenal transplant erythrocytosis: a review of 53 patients. Kidney Int 23:713–737 Wickre CG, Normal DJ, Bennison A et al (1983) Postrenal transplant erythrocytosis: a review of 53 patients. Kidney Int 23:713–737
16.
Zurück zum Zitat Sanchez-Giron F, Alvarez-Mora F (2008) Reduction of blood loss from laboratory testing in hospitalized adult patients using small-volume (pediatric) tubes. Arch Pathol Lab Med 132:1916–1919PubMed Sanchez-Giron F, Alvarez-Mora F (2008) Reduction of blood loss from laboratory testing in hospitalized adult patients using small-volume (pediatric) tubes. Arch Pathol Lab Med 132:1916–1919PubMed
17.
Zurück zum Zitat Foulke GE, Harlow DJ (1989) Effective measures for reducing blood loss from diagnostic laboratory tests in intensive care unit patients. Crit Care Med 17:1143–1145PubMed Foulke GE, Harlow DJ (1989) Effective measures for reducing blood loss from diagnostic laboratory tests in intensive care unit patients. Crit Care Med 17:1143–1145PubMed
18.
Zurück zum Zitat Smoller BR, Kruskall MS, Horowitz GL (1989) Reducing adult phlebotomy blood loss with the use of pediatric-sized blood collection tubes. Am J Clin Pathol 91:701–703PubMed Smoller BR, Kruskall MS, Horowitz GL (1989) Reducing adult phlebotomy blood loss with the use of pediatric-sized blood collection tubes. Am J Clin Pathol 91:701–703PubMed
20.
Zurück zum Zitat Nampoory MRN, Johny KV, Al-Hilali N, Seshadri MS, Kanagasabhapathy AS (1996) Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant patients with normal renal function. Nephrol Dial Transplant 11:177–181PubMed Nampoory MRN, Johny KV, Al-Hilali N, Seshadri MS, Kanagasabhapathy AS (1996) Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant patients with normal renal function. Nephrol Dial Transplant 11:177–181PubMed
22.
Zurück zum Zitat Kessler M (1995) Erythropoietin and erythropoiesis in renal transplantation. Nephrol Dial Transplant 10S:114–116 Kessler M (1995) Erythropoietin and erythropoiesis in renal transplantation. Nephrol Dial Transplant 10S:114–116
25.
Zurück zum Zitat Lorenz M, Kletzmayr J, Perschl A, Furrer A, Horl WH, Sunder-Plassmann G (2002) Anemia and iron deficiencies among long-term renal transplant recipients. J Am Soc Nephrol 13:794–797PubMed Lorenz M, Kletzmayr J, Perschl A, Furrer A, Horl WH, Sunder-Plassmann G (2002) Anemia and iron deficiencies among long-term renal transplant recipients. J Am Soc Nephrol 13:794–797PubMed
27.
Zurück zum Zitat Miles AM, Markell MS, Daskalakis P et al (1997) Anemia following renal transplantation: erythropoietin response and iron deficiency. Clin Transplant 11:313–315PubMed Miles AM, Markell MS, Daskalakis P et al (1997) Anemia following renal transplantation: erythropoietin response and iron deficiency. Clin Transplant 11:313–315PubMed
33.
Zurück zum Zitat Sturm I, Watschinger B, Geissler K et al (1996) Chronic parvovirus B19 infection-associated pure red cell aplasia anaemia in a kidney transplant recipient. Nephrol Dial Transplant 11:1367–1370PubMed Sturm I, Watschinger B, Geissler K et al (1996) Chronic parvovirus B19 infection-associated pure red cell aplasia anaemia in a kidney transplant recipient. Nephrol Dial Transplant 11:1367–1370PubMed
34.
Zurück zum Zitat Torres-Madriz G, Boucher HW (2008) Perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients. Clin Infect Dis 47:702–711. doi:10.1086/590934 PubMedCrossRef Torres-Madriz G, Boucher HW (2008) Perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients. Clin Infect Dis 47:702–711. doi:10.​1086/​590934 PubMedCrossRef
36.
Zurück zum Zitat Arthurs SK, Eid AJ, Pedersen RA et al (2008) Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis 46:840–846. doi:10.1086/528718 PubMedCrossRef Arthurs SK, Eid AJ, Pedersen RA et al (2008) Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis 46:840–846. doi:10.​1086/​528718 PubMedCrossRef
38.
Zurück zum Zitat Keithi-Reddy SRR, Chakravarthi RM, Hussaini SM, Venkatapuram RR, Murthy JMK (2007) Cytomegalovirus disease with Guillain-Barre syndrome in a cadaver renal allograft recipient: cause or coincidence. Int Urol Nephrol 39:967–970. doi:10.1007/s11255-007-9197-7 PubMedCrossRef Keithi-Reddy SRR, Chakravarthi RM, Hussaini SM, Venkatapuram RR, Murthy JMK (2007) Cytomegalovirus disease with Guillain-Barre syndrome in a cadaver renal allograft recipient: cause or coincidence. Int Urol Nephrol 39:967–970. doi:10.​1007/​s11255-007-9197-7 PubMedCrossRef
40.
Zurück zum Zitat Reddehase MJ, Dreher-Stumpp L, Angele P et al (1992) Hematopoietic stem cell deficiency resulting from cytomegalovirus infection of bone marrow stroma. Ann Hematol 64:A125. doi:10.1007/BF01715364 PubMedCrossRef Reddehase MJ, Dreher-Stumpp L, Angele P et al (1992) Hematopoietic stem cell deficiency resulting from cytomegalovirus infection of bone marrow stroma. Ann Hematol 64:A125. doi:10.​1007/​BF01715364 PubMedCrossRef
44.
Zurück zum Zitat Singh N, Carrigan DR (1996) Human herpesvirus-6 in transplantation: an emerging pathogen. Ann Intern Med 124:1065–1071PubMed Singh N, Carrigan DR (1996) Human herpesvirus-6 in transplantation: an emerging pathogen. Ann Intern Med 124:1065–1071PubMed
47.
Zurück zum Zitat Ryan DH, Cohen HJ (2005) Bone marrow examination. In: Hoffman R, Benz EJ, Shattil SJ et al (eds) Hematology: basic principles and practice, 4th ed. edn. Elsevier Churchill Livingstone, Philadelphia, pp 2656–2671 Ryan DH, Cohen HJ (2005) Bone marrow examination. In: Hoffman R, Benz EJ, Shattil SJ et al (eds) Hematology: basic principles and practice, 4th ed. edn. Elsevier Churchill Livingstone, Philadelphia, pp 2656–2671
48.
Zurück zum Zitat Davis PL, Ripka JW (1964) Pancytopenia with leukemia-like picture. Effects of histoplasmosis. JAMA 188:184–185PubMed Davis PL, Ripka JW (1964) Pancytopenia with leukemia-like picture. Effects of histoplasmosis. JAMA 188:184–185PubMed
49.
Zurück zum Zitat Einollahi B, Lessan-Pezeshki M, Pourfarziani V et al (2008) Invasive fungal infections following renal transplantation: a review of 2410 recipients. Ann Transplant 13:55–58PubMed Einollahi B, Lessan-Pezeshki M, Pourfarziani V et al (2008) Invasive fungal infections following renal transplantation: a review of 2410 recipients. Ann Transplant 13:55–58PubMed
51.
Zurück zum Zitat Kennedy GA, Kay TD, Johnson DW et al (2002) Neutrophil dysplasia characterized by pseudo-Pelger-Huet anomaly occurring with the use of mycophenolate mofetil and ganciclovir following renal transplantation: a report of five cases. Pathology 34:263. doi:10.1080/0031302022013136 PubMedCrossRef Kennedy GA, Kay TD, Johnson DW et al (2002) Neutrophil dysplasia characterized by pseudo-Pelger-Huet anomaly occurring with the use of mycophenolate mofetil and ganciclovir following renal transplantation: a report of five cases. Pathology 34:263. doi:10.​1080/​0031302022013136​ PubMedCrossRef
52.
Zurück zum Zitat Gondo H, Okamura C, Osaki K et al (2000) Acquired Pelger-Huet anomaly in association with concomitant tacrolimus and fluconazole therapy following allogeneic bone marrow transplantation. Bone Marrow Transplant 26:1255. doi:10.1038/sj.bmt.1702682 PubMedCrossRef Gondo H, Okamura C, Osaki K et al (2000) Acquired Pelger-Huet anomaly in association with concomitant tacrolimus and fluconazole therapy following allogeneic bone marrow transplantation. Bone Marrow Transplant 26:1255. doi:10.​1038/​sj.​bmt.​1702682 PubMedCrossRef
57.
Zurück zum Zitat Rerolle JP, Szelag JC, LeMeur Y (2007) Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipients. Nephrol Dial Transplant 22:671–672. doi:10.1093/ndt/gfl539 PubMedCrossRef Rerolle JP, Szelag JC, LeMeur Y (2007) Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipients. Nephrol Dial Transplant 22:671–672. doi:10.​1093/​ndt/​gfl539 PubMedCrossRef
58.
Zurück zum Zitat Chiurchiu C, Ruggenenti P, Remuzzi G (2002) Thrombotic microangiopathy in renal transplantation. Ann Transplant 7:28–33PubMed Chiurchiu C, Ruggenenti P, Remuzzi G (2002) Thrombotic microangiopathy in renal transplantation. Ann Transplant 7:28–33PubMed
59.
Zurück zum Zitat Marinella MA (2003) Thrombotic thrombocytopenic purpura. In: Marinella MA (ed) Frequently overlooked diagnoses in acute care. Hanley and Belfus, Philadelphia, pp 107-110 Marinella MA (2003) Thrombotic thrombocytopenic purpura. In: Marinella MA (ed) Frequently overlooked diagnoses in acute care. Hanley and Belfus, Philadelphia, pp 107-110
60.
Zurück zum Zitat Marinella MA (In press) Thrombotic thrombocytopenic purpura. In: Marinella MA (ed) Handbook of oncologic emergencies. Jones and Bartlett, Sudbury, MA Marinella MA (In press) Thrombotic thrombocytopenic purpura. In: Marinella MA (ed) Handbook of oncologic emergencies. Jones and Bartlett, Sudbury, MA
61.
Zurück zum Zitat Pratap B, Abraham G, Srinivas CN, Bhaskar S (2007) Post-renal transplant hemolytic uremic syndrome following combination therapy with tacrolimus and everolimus. Saudi J Kidney Dis Transplant 18:609–612 Pratap B, Abraham G, Srinivas CN, Bhaskar S (2007) Post-renal transplant hemolytic uremic syndrome following combination therapy with tacrolimus and everolimus. Saudi J Kidney Dis Transplant 18:609–612
62.
Zurück zum Zitat Boctor FN (2006) Tacrolimus (FK506) associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in lung transplant salvage with a plasmapheresis and cyclosporine. Egypt J Immunol 13:95–99PubMed Boctor FN (2006) Tacrolimus (FK506) associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in lung transplant salvage with a plasmapheresis and cyclosporine. Egypt J Immunol 13:95–99PubMed
64.
Zurück zum Zitat Ardalan MA (2006) Review of thrombotic microangiopathy (TMA), and post-renal transplant TMA. Saudi J Kidney Dis Transplant 17:235–244 Ardalan MA (2006) Review of thrombotic microangiopathy (TMA), and post-renal transplant TMA. Saudi J Kidney Dis Transplant 17:235–244
65.
Zurück zum Zitat Lin CC, King KL, Chao YW, Yang AH, Chang CF, Yang WC (2003) Tacrolimus-associated hemolytic uremic syndrome: a case analysis. J Nephrol 16:580–585PubMed Lin CC, King KL, Chao YW, Yang AH, Chang CF, Yang WC (2003) Tacrolimus-associated hemolytic uremic syndrome: a case analysis. J Nephrol 16:580–585PubMed
68.
Zurück zum Zitat Stevenson JA, Dumke A, Glassock RJ, Raijfer J, Cohen AH (1982) Thrombotic microangiopathy: recurrence following renal transplant and response to plasma infusion. Am J Nephrol 2:227–231. doi:10.1159/000166651 PubMedCrossRef Stevenson JA, Dumke A, Glassock RJ, Raijfer J, Cohen AH (1982) Thrombotic microangiopathy: recurrence following renal transplant and response to plasma infusion. Am J Nephrol 2:227–231. doi:10.​1159/​000166651 PubMedCrossRef
72.
Zurück zum Zitat Gurkan A, Yakupoglu U, Yavuz A et al (2006) Hemophagocytic syndrome in kidney transplant recipients: report of four cases from a single center. Acta Haematol 116:108–113. doi:10.1159/000093640 PubMedCrossRef Gurkan A, Yakupoglu U, Yavuz A et al (2006) Hemophagocytic syndrome in kidney transplant recipients: report of four cases from a single center. Acta Haematol 116:108–113. doi:10.​1159/​000093640 PubMedCrossRef
77.
Zurück zum Zitat Leblond V, Sutton L, Dorent R et al (1995) Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. J Clin Oncol 13:961–968PubMed Leblond V, Sutton L, Dorent R et al (1995) Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. J Clin Oncol 13:961–968PubMed
78.
Zurück zum Zitat Leblond V, Davi F, Charlotte F et al (1998) Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? J Clin Oncol 16:2052–2059PubMed Leblond V, Davi F, Charlotte F et al (1998) Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? J Clin Oncol 16:2052–2059PubMed
80.
Zurück zum Zitat Blaes AH, Peterson BA, Bartlett N, Dunn DL, Morrison VA (2005) Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial. Cancer 104:1661–1667. doi:10.1002/cncr.21391 PubMedCrossRef Blaes AH, Peterson BA, Bartlett N, Dunn DL, Morrison VA (2005) Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial. Cancer 104:1661–1667. doi:10.​1002/​cncr.​21391 PubMedCrossRef
81.
Zurück zum Zitat Caillard S, Lachat V, Moulin B (2000) Posttransplant lymphoproliferative disorders in renal allograft recipients: report of 53 cases of a French multicenter study. PTLD French Working Group. Transpl Int 13((Suppl)):S388–S393. doi:10.1007/s001470050368 PubMedCrossRef Caillard S, Lachat V, Moulin B (2000) Posttransplant lymphoproliferative disorders in renal allograft recipients: report of 53 cases of a French multicenter study. PTLD French Working Group. Transpl Int 13((Suppl)):S388–S393. doi:10.​1007/​s001470050368 PubMedCrossRef
82.
Zurück zum Zitat Khan MS, Ahmed S, Challacombe B, Goldsmith D, Steward M (2008) Post-transplant lymphoproliferative disorder (PTLD) presenting as painful lymphocele 12 years after a cadaveric renal transplant. Int Urol Nephrol 40:547–550. doi:10.1007/s11255-008-9367-2 PubMedCrossRef Khan MS, Ahmed S, Challacombe B, Goldsmith D, Steward M (2008) Post-transplant lymphoproliferative disorder (PTLD) presenting as painful lymphocele 12 years after a cadaveric renal transplant. Int Urol Nephrol 40:547–550. doi:10.​1007/​s11255-008-9367-2 PubMedCrossRef
83.
Zurück zum Zitat Colleoni GW, Oliveira JS, Borducchi DM et al (2000) Post-transplant lymphoproliferative disorders (PTLD) after renal transplantation: management and evolution of seven cases among 1002 renal transplants in Sao Paulo, Brazil. Leuk Lymphoma 39:145–150PubMed Colleoni GW, Oliveira JS, Borducchi DM et al (2000) Post-transplant lymphoproliferative disorders (PTLD) after renal transplantation: management and evolution of seven cases among 1002 renal transplants in Sao Paulo, Brazil. Leuk Lymphoma 39:145–150PubMed
85.
Zurück zum Zitat Choquet S, Leblond V, Lager U et al (2003) Efficacy of CHOP regimen as first line therapy in posttransplantation lymphoproliferative disorders (PTLD). A retrospective study on 25 cases. Blood 102:496 abstract Choquet S, Leblond V, Lager U et al (2003) Efficacy of CHOP regimen as first line therapy in posttransplantation lymphoproliferative disorders (PTLD). A retrospective study on 25 cases. Blood 102:496 abstract
87.
Zurück zum Zitat Lee JJ, Lam MS, Rosenberg A (2007) Role of chemotherapy and rituximab for treatment of posttransplant lymphoproliferative disorders in solid organ transplantation. Ann Pharmacother 41:1648–1659. doi:10.1345/aph.1K175 PubMedCrossRef Lee JJ, Lam MS, Rosenberg A (2007) Role of chemotherapy and rituximab for treatment of posttransplant lymphoproliferative disorders in solid organ transplantation. Ann Pharmacother 41:1648–1659. doi:10.​1345/​aph.​1K175 PubMedCrossRef
88.
Zurück zum Zitat Wu H, Wasik MA, Przybylski G et al (2000) Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients. Am J Clin Pathol 113:487–496. doi:10.1309/YTTC-F55W-K9CP-EPX5 PubMedCrossRef Wu H, Wasik MA, Przybylski G et al (2000) Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients. Am J Clin Pathol 113:487–496. doi:10.​1309/​YTTC-F55W-K9CP-EPX5 PubMedCrossRef
89.
Zurück zum Zitat Tey SK, Marlton PV, Hawley CM, Norris D, Gill DS (2008) Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen. Am J Hematol 83:30–333. doi:10.1002/ajh.21062 CrossRef Tey SK, Marlton PV, Hawley CM, Norris D, Gill DS (2008) Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen. Am J Hematol 83:30–333. doi:10.​1002/​ajh.​21062 CrossRef
91.
Zurück zum Zitat Farcet JP, Gaulard P, Marolleau JP et al (1990) Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood 75:2213–2219PubMed Farcet JP, Gaulard P, Marolleau JP et al (1990) Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood 75:2213–2219PubMed
92.
Zurück zum Zitat Volk HD, Reinke P, Neuhaus K, Feibig H, von Baehr R (1989) Expansion of a CD3+ 4-8- TCR alpha/beta- T lymphocyte population in renal allograft recipients. Transplantation 47:556–558PubMedCrossRef Volk HD, Reinke P, Neuhaus K, Feibig H, von Baehr R (1989) Expansion of a CD3+ 4-8- TCR alpha/beta- T lymphocyte population in renal allograft recipients. Transplantation 47:556–558PubMedCrossRef
102.
Zurück zum Zitat Koca E, Cetiner D, Goker H et al (2005) Complete cytogenetic remission with imatinib mesylate treatment in chronic myelogenous leukemia (CML) developed after renal transplantation. Clin Nephrol 64:324–326PubMed Koca E, Cetiner D, Goker H et al (2005) Complete cytogenetic remission with imatinib mesylate treatment in chronic myelogenous leukemia (CML) developed after renal transplantation. Clin Nephrol 64:324–326PubMed
104.
Zurück zum Zitat Gorschluter M, Glasmacher A, Risse F, Klein B, Klehr HU, Mezger J (1997) Successful induction and consolidation therapy of acute myeloid leukaemia in a renal allograft recipient. Nephrol Dial Transplant 12:593–595. doi:10.1093/ndt/12.3.593 PubMedCrossRef Gorschluter M, Glasmacher A, Risse F, Klein B, Klehr HU, Mezger J (1997) Successful induction and consolidation therapy of acute myeloid leukaemia in a renal allograft recipient. Nephrol Dial Transplant 12:593–595. doi:10.​1093/​ndt/​12.​3.​593 PubMedCrossRef
105.
Metadaten
Titel
Hematologic abnormalities following renal transplantation
verfasst von
Mark A. Marinella
Publikationsdatum
01.03.2010
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 1/2010
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-009-9558-5

Weitere Artikel der Ausgabe 1/2010

International Urology and Nephrology 1/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.